C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/4706 (2006.01) A61K 31/4709 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61K 31/517 (2006.01) A61P 19/10 (2006.01) C07D 215/46 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2662281
The present invention relates to (het)aryl-3-[(het)arylpiperidin-4-yl]amides, to processes for their preparation and to their use for producing pharmaceutical compositions for treatment of disorders and indications connected to the EP2 receptor.
L'invention concerne des (hét)aryle-3-[(hét)arylpipéridine-4-yl]amides, des procédés de préparation de ceux-ci et leur utilisation dans la production de compositions pharmaceutiques destinées au traitement de troubles, ainsi que des indications relatives au récepteur EP2.
Braeuer Nico
Buchmann Bernd
Koppitz Marcus
Langer Gernot
Lindenthal Bernhard
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1464027